CN104003930B - 一种盐酸罗哌卡因的制备方法 - Google Patents
一种盐酸罗哌卡因的制备方法 Download PDFInfo
- Publication number
- CN104003930B CN104003930B CN201410263792.1A CN201410263792A CN104003930B CN 104003930 B CN104003930 B CN 104003930B CN 201410263792 A CN201410263792 A CN 201410263792A CN 104003930 B CN104003930 B CN 104003930B
- Authority
- CN
- China
- Prior art keywords
- ropivacaine
- hydrochloric acid
- volume
- parts
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Description
试验序号 | 起始原料(g) | 溶剂A | 产物(g) | 收率% |
2-1 | 10.0 | 乙酸乙酯 | 8.33 | 46.2 |
2-2 | 10.0 | 二氯甲烷 | 14.72 | 81.9 |
2-3 | 10.0 | 石油醚 | 9.65 | 53.2 |
2-4 | 10.0 | 甲苯 | 11.31 | 62.9 |
试验序号 | 中间体(II)(g) | A:B:中间体(II) | 产物(g) | 光学纯度% | 收率% |
5-1 | 15.0 | 0:0.2:1 | 16.26 | 57.14 | 85.1 |
5-2 | 15.0 | 0.1:0.1:1 | 9.07 | 81.33 | 47.5 |
5-3 | 15.0 | 0.1:0.2:1 | 7.76 | 99.10 | 40.6 |
5-4 | 15.0 | 0.2:0.2:1 | 6.29 | 95.25 | 32.97 --> |
5-5 | 15.0 | 0.2:0.4:1 | 6.76 | 92.56 | 35.4 |
试验序号 | 酒石酸盐(g) | 成盐方式 | 产物(g) | 光学纯度% | 收率% |
6-1 | 8.0 | 滴加浓盐酸 | 6.44 | 99.09 | 85.4 |
6-2 | 8.0 | 通入HCl气体 | 6.50 | 99.11 | 86.2 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410263792.1A CN104003930B (zh) | 2014-06-13 | 2014-06-13 | 一种盐酸罗哌卡因的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410263792.1A CN104003930B (zh) | 2014-06-13 | 2014-06-13 | 一种盐酸罗哌卡因的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104003930A CN104003930A (zh) | 2014-08-27 |
CN104003930B true CN104003930B (zh) | 2016-06-08 |
Family
ID=51364865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410263792.1A Active CN104003930B (zh) | 2014-06-13 | 2014-06-13 | 一种盐酸罗哌卡因的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104003930B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107325041A (zh) * | 2017-06-20 | 2017-11-07 | 广州市桐晖药业有限公司 | 一种盐酸罗哌卡因的制备方法 |
CN107501167A (zh) * | 2017-07-24 | 2017-12-22 | 江西永通科技股份有限公司 | 一种盐酸布比卡因的制备方法 |
CN109503465B (zh) * | 2019-01-10 | 2021-07-02 | 河北一品制药股份有限公司 | 一种盐酸罗哌卡因中间体的制备及纯化方法 |
CN109867602A (zh) * | 2019-03-21 | 2019-06-11 | 济南大学 | 一种二乙酰乙酰酒石酸的制备方法和用途 |
CN113735760B (zh) * | 2020-05-29 | 2023-08-01 | 扬子江药业集团江苏海慈生物药业有限公司 | 一种盐酸罗哌卡因的制备方法 |
CN113105386B (zh) * | 2021-04-10 | 2022-11-25 | 河北一品制药股份有限公司 | 一种盐酸罗哌卡因一水合物工业化的制备方法 |
CN115057810A (zh) * | 2022-05-30 | 2022-09-16 | 山东科源制药股份有限公司 | 一种盐酸罗哌卡因中间体的制备方法 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB775750A (en) * | 1955-04-28 | 1957-05-29 | Bofors Ab | Method of preparing amides of n-alkyl piperidine mono-carboxylic acid and n-alkyl pyrrolidine -a-monocarboxylic acid |
GB949729A (en) * | 1960-11-15 | 1964-02-19 | Bofors Ab | Substituted-piperidine carboxylic acid amide salts and their preparation |
US4695576A (en) * | 1984-07-09 | 1987-09-22 | Astra Lake Medel Aktiebolag | L-N-n-propylpipecolic acid-2,6-xylidide |
CN1161689A (zh) * | 1994-10-25 | 1997-10-08 | 奇罗斯恩有限公司 | 左旋丁哌卡因及其类似物的结晶方法 |
US5777124A (en) * | 1994-10-25 | 1998-07-07 | Chiroscience Limited | Process for preparing levobupivacaine and analogues thereof |
CN1189822A (zh) * | 1995-05-16 | 1998-08-05 | 阿斯特拉公司 | 制备罗哌卡因盐酸盐-水合物的新方法 |
EP1433782A1 (en) * | 2001-09-10 | 2004-06-30 | Mercian Corporation | Process for producing pipecolamide derivative |
CN101613313A (zh) * | 2009-08-07 | 2009-12-30 | 珠海润都民彤制药有限公司 | 布比卡因光学异构体的拆分 |
WO2010084516A1 (en) * | 2009-01-23 | 2010-07-29 | Jubilant Organosys Limited | Process for producing optically active n-alkyl-piperidine-2-carboxanilide |
CN102659763A (zh) * | 2012-04-27 | 2012-09-12 | 南京优科生物医药研究有限公司 | 一种右旋兰索拉唑合成与纯化的方法 |
WO2014009964A1 (en) * | 2012-07-11 | 2014-01-16 | Neon Laboratories Limited | Process for enantiomeric enrichment of 2 ', 6 ' - pipecoloxylidide |
-
2014
- 2014-06-13 CN CN201410263792.1A patent/CN104003930B/zh active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB775750A (en) * | 1955-04-28 | 1957-05-29 | Bofors Ab | Method of preparing amides of n-alkyl piperidine mono-carboxylic acid and n-alkyl pyrrolidine -a-monocarboxylic acid |
GB949729A (en) * | 1960-11-15 | 1964-02-19 | Bofors Ab | Substituted-piperidine carboxylic acid amide salts and their preparation |
US4695576A (en) * | 1984-07-09 | 1987-09-22 | Astra Lake Medel Aktiebolag | L-N-n-propylpipecolic acid-2,6-xylidide |
CN1161689A (zh) * | 1994-10-25 | 1997-10-08 | 奇罗斯恩有限公司 | 左旋丁哌卡因及其类似物的结晶方法 |
US5777124A (en) * | 1994-10-25 | 1998-07-07 | Chiroscience Limited | Process for preparing levobupivacaine and analogues thereof |
CN1189822A (zh) * | 1995-05-16 | 1998-08-05 | 阿斯特拉公司 | 制备罗哌卡因盐酸盐-水合物的新方法 |
EP1433782A1 (en) * | 2001-09-10 | 2004-06-30 | Mercian Corporation | Process for producing pipecolamide derivative |
WO2010084516A1 (en) * | 2009-01-23 | 2010-07-29 | Jubilant Organosys Limited | Process for producing optically active n-alkyl-piperidine-2-carboxanilide |
CN101613313A (zh) * | 2009-08-07 | 2009-12-30 | 珠海润都民彤制药有限公司 | 布比卡因光学异构体的拆分 |
CN102659763A (zh) * | 2012-04-27 | 2012-09-12 | 南京优科生物医药研究有限公司 | 一种右旋兰索拉唑合成与纯化的方法 |
WO2014009964A1 (en) * | 2012-07-11 | 2014-01-16 | Neon Laboratories Limited | Process for enantiomeric enrichment of 2 ', 6 ' - pipecoloxylidide |
Non-Patent Citations (4)
Title |
---|
三光气法合成盐酸罗哌卡因;叶姣,等;《合成化学》;20060831;第14卷(第04期);第418-419页 * |
拆分法制L-2-哌啶酸;李传润,等;《安徽化工》;20021230(第06期);第20-21页 * |
盐酸罗哌卡因和盐酸布比卡因的合成工艺研究;蒋瑶;《湖南大学硕士学位论文》;20061115;第7-18页 * |
罗哌卡因合成方法研究进展;李龙星,等;《化工时刊》;20110430;第25卷(第04期);第44-45页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104003930A (zh) | 2014-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104003930B (zh) | 一种盐酸罗哌卡因的制备方法 | |
CN100436429C (zh) | 具有喹唑二酮骨架的苯丙氨酸衍生物的制造方法及制造中间体 | |
CN104804728B (zh) | 一种荧光增强型苯硫酚荧光探针的制备及应用 | |
CN104672238B (zh) | 一种利格列汀的制备方法 | |
CN104926790A (zh) | 一种高纯度 Vonoprazan Fumarate化合物及其中间体、杂质以及它们的制备方法 | |
CN108368126A (zh) | 用于制备1,3-苯并间二氧杂环戊烯杂环化合物的方法 | |
CN105330582B (zh) | (r)-4-羟基-2-氧代-1-吡咯烷乙酰胺的制备方法 | |
CN113735828A (zh) | 一种靶向降解egfr的化合物及其制备方法和应用 | |
CN102863359B (zh) | 一种抗流感药物的合成方法 | |
ZA200400844B (en) | Process for producing pyridine compound | |
EP3653607B1 (en) | Process for the preparation of enantiomerically enriched 3-aminopiperidine | |
CN106632280A (zh) | 一种制备盐酸阿呋唑嗪的方法 | |
CN102952139B (zh) | 反式-3a-氟吡咯烷[3,4-C]并环化合物及其制备方法 | |
CN105732445B (zh) | 达泊西汀中间体及其制备方法 | |
CN106632312A (zh) | 一种阿哌沙班有关物质、中间体、制备方法及其应用 | |
CN104072407B (zh) | 一种Rho激酶抑制剂Y27632化合物的制备方法 | |
CN103539796B (zh) | 一种左旋吡喹酮及其中间体的制备方法 | |
CN103755715B (zh) | 苯并呋喃并[2,3-c]吡啶化合物及其合成方法 | |
CN103304438A (zh) | N-取代水杨酰胺类化合物、制备方法及应用 | |
CN105218519A (zh) | 一种达比加群酯中间体的制备方法 | |
CN1159274C (zh) | 1,1,1-三氟-2,2-二氯乙烷的提纯方法 | |
CN109608378A (zh) | 一种卡托普利异构体的制备方法 | |
CN109517003A (zh) | 一种克瑞沙硼的制备方法 | |
CN104558103B (zh) | 一种阿加曲班中间体的制备方法 | |
CN104628600B (zh) | 一种(s)-甲基多巴中间体化合物的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: The 250101 Ji'nan Road, Shandong province hi tech Development Zone, No. 322 room 501-506 Applicant after: Shandong Jin He drug development research company limited Address before: The 250101 Ji'nan Road, Shandong province hi tech Development Zone, No. 322 room 501-506 Applicant before: Shandong ARURA Pharmaceutical Research & Development Co., Ltd. |
|
CB03 | Change of inventor or designer information |
Inventor after: Zhang Dong Inventor after: Wang Lei Inventor after: Peng Kun Inventor after: Ma Ning Inventor after: Wang Jingkai Inventor after: Dong Yubo Inventor before: Zhang Dong Inventor before: Peng Kun Inventor before: Ma Ning Inventor before: Wang Jingkai Inventor before: Dong Yubo |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 250101 Shandong Province Jinan Hi-tech Zone Comprehensive Bonded Zone No. 1 North Section of Gangxing No. 3 Road Jinan Yaogu R&D Platform Area No. 3 Floor 8001 Patentee after: Jinhe Tibetan Medicine (Shandong) Health Industry Co.,Ltd. Address before: 250101 room 501-506, Shun Feng Road, Ji'nan hi tech Zone, Shandong, 501-506 Patentee before: SHANDONG JINHE DRUG RESEARCH DEVELOPMENT Co.,Ltd. |
|
CP03 | Change of name, title or address |